Neurofeedback as a treatment for major depressive disorder--a pilot study.

BACKGROUND: There is growing interest in neurofeedback as a treatment for major depressive disorder. Reduction of asymmetry of alpha-activity between left and right prefrontal areas with neurofeedback has been postulated as effective in earlier studies. Unfortunately, methodological shortcomings lim...

Full description

Bibliographic Details
Main Authors: Frenk Peeters, Mare Oehlen, Jacco Ronner, Jim van Os, Richel Lousberg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3958393?pdf=render
_version_ 1819037776577822720
author Frenk Peeters
Mare Oehlen
Jacco Ronner
Jim van Os
Richel Lousberg
author_facet Frenk Peeters
Mare Oehlen
Jacco Ronner
Jim van Os
Richel Lousberg
author_sort Frenk Peeters
collection DOAJ
description BACKGROUND: There is growing interest in neurofeedback as a treatment for major depressive disorder. Reduction of asymmetry of alpha-activity between left and right prefrontal areas with neurofeedback has been postulated as effective in earlier studies. Unfortunately, methodological shortcomings limit conclusions that can be drawn from these studies. In a pilot-study, we investigated the effectiveness of reduction of asymmetry of alpha-activity with neurofeedback in depressed participants with the use of a stringent methodological approach. METHODS: Nine participants meeting DSM-IV criteria for major depressive disorder were treated with a maximum of 30 neurofeedback-sessions, aimed at reducing asymmetry of alpha-activity, over a 10-week period. No changes in the use of antidepressants were allowed 6 weeks before and during the intervention. Changes in depressive symptomatology were assessed with the Quick Inventory of Depressive Symptoms, self-report version. RESULTS: We observed response in 1 and remission in 4 out of a total of 9 participants. The effectiveness appeared largest in female participants. The mean asymmetry of alpha-activity decreased significantly over sessions in a quadratic fashion. This decrease was associated with clinical response. CONCLUSIONS: This pilot study suggests that neurofeedback aimed at a reduction of frontal asymmetry of alpha-activity may be effective as a treatment for depression. However, this was an open label pilot study. Non-specific effects of the procedure and/or a beneficial natural course may have confounded the results. Randomized controlled trials will have to establish the efficacy of neurofeedback for depression. TRIAL REGISTRATION: Nederlands Trial Register NTR1629.
first_indexed 2024-12-21T08:26:48Z
format Article
id doaj.art-b2f341859ed746f28c18ee00ffa3cfd9
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T08:26:48Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b2f341859ed746f28c18ee00ffa3cfd92022-12-21T19:10:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0193e9183710.1371/journal.pone.0091837Neurofeedback as a treatment for major depressive disorder--a pilot study.Frenk PeetersMare OehlenJacco RonnerJim van OsRichel LousbergBACKGROUND: There is growing interest in neurofeedback as a treatment for major depressive disorder. Reduction of asymmetry of alpha-activity between left and right prefrontal areas with neurofeedback has been postulated as effective in earlier studies. Unfortunately, methodological shortcomings limit conclusions that can be drawn from these studies. In a pilot-study, we investigated the effectiveness of reduction of asymmetry of alpha-activity with neurofeedback in depressed participants with the use of a stringent methodological approach. METHODS: Nine participants meeting DSM-IV criteria for major depressive disorder were treated with a maximum of 30 neurofeedback-sessions, aimed at reducing asymmetry of alpha-activity, over a 10-week period. No changes in the use of antidepressants were allowed 6 weeks before and during the intervention. Changes in depressive symptomatology were assessed with the Quick Inventory of Depressive Symptoms, self-report version. RESULTS: We observed response in 1 and remission in 4 out of a total of 9 participants. The effectiveness appeared largest in female participants. The mean asymmetry of alpha-activity decreased significantly over sessions in a quadratic fashion. This decrease was associated with clinical response. CONCLUSIONS: This pilot study suggests that neurofeedback aimed at a reduction of frontal asymmetry of alpha-activity may be effective as a treatment for depression. However, this was an open label pilot study. Non-specific effects of the procedure and/or a beneficial natural course may have confounded the results. Randomized controlled trials will have to establish the efficacy of neurofeedback for depression. TRIAL REGISTRATION: Nederlands Trial Register NTR1629.http://europepmc.org/articles/PMC3958393?pdf=render
spellingShingle Frenk Peeters
Mare Oehlen
Jacco Ronner
Jim van Os
Richel Lousberg
Neurofeedback as a treatment for major depressive disorder--a pilot study.
PLoS ONE
title Neurofeedback as a treatment for major depressive disorder--a pilot study.
title_full Neurofeedback as a treatment for major depressive disorder--a pilot study.
title_fullStr Neurofeedback as a treatment for major depressive disorder--a pilot study.
title_full_unstemmed Neurofeedback as a treatment for major depressive disorder--a pilot study.
title_short Neurofeedback as a treatment for major depressive disorder--a pilot study.
title_sort neurofeedback as a treatment for major depressive disorder a pilot study
url http://europepmc.org/articles/PMC3958393?pdf=render
work_keys_str_mv AT frenkpeeters neurofeedbackasatreatmentformajordepressivedisorderapilotstudy
AT mareoehlen neurofeedbackasatreatmentformajordepressivedisorderapilotstudy
AT jaccoronner neurofeedbackasatreatmentformajordepressivedisorderapilotstudy
AT jimvanos neurofeedbackasatreatmentformajordepressivedisorderapilotstudy
AT richellousberg neurofeedbackasatreatmentformajordepressivedisorderapilotstudy